ACTIVE

ALPHAR GILLY

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

104,8 k €

+3.3% YoY

Gross margin

136,8 k €

+6.7% YoY

Equity

725 k €

-2.8% YoY

What does ALPHAR GILLY do?

ALPHAR GILLY is a Private limited company incorporated in 2005. Its main activity is: Buying and selling of own real estate. Its registered office is in Charleroi.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0874.513.594

Incorporation

16/06/2005

Legal form

Private limited company

Registered office

Chaussée Impériale 42
6060 Charleroi · WallonieSee on map

Contributed capital

137 500,00 €

Latest accounts

31/12/2025

Activities (NACE)

68100Buying and selling of own real estate· main 68110Buying and selling of own real estate 70120Activities of head offices 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	136,8 k €	+6.7%	128,2 k €	+30.8%	98,1 k €	+46.3%	67 k €	+7.4%	62,4 k €	+51.0%	41,3 k €	-2.7%	42,5 k €	-38.2%	68,8 k €	-4.2%	71,8 k €	-6.9%	77,1 k €		–		–		–		–		–		–		–		–		–
EBITDA	135,8 k €	+6.7%	127,3 k €	+31.1%	97,1 k €	+46.8%	66,1 k €	+7.5%	61,5 k €	+52.1%	40,5 k €	-2.8%	41,6 k €	-38.7%	67,9 k €	-4.3%	71 k €	-7.0%	76,3 k €	+1.7%	75 k €	+28.5%	58,4 k €	+117%	26,9 k €	-55.0%	59,7 k €	+44.2%	41,4 k €	-42.0%	71,4 k €	-11.1%	80,3 k €	+1.2%	79,4 k €	-20.5%	99,8 k €
Operating result	135,8 k €	+6.7%	127,3 k €	+31.1%	97,1 k €	+46.8%	66,1 k €	+7.5%	61,5 k €	+52.1%	40,5 k €	-2.8%	41,6 k €	-38.7%	67,9 k €	-4.3%	71 k €	-7.0%	76,3 k €	+1.7%	75 k €	+28.7%	58,3 k €	+118%	26,7 k €	-55.2%	59,5 k €	+44.3%	41,3 k €	-42.2%	71,3 k €	-7.0%	76,7 k €	+0.1%	76,6 k €	-21.4%	97,5 k €
Net result	104,8 k €	+3.3%	101,4 k €	+26.6%	80,1 k €	+64.5%	48,7 k €	+2.0%	47,7 k €	+64.2%	29 k €	+17.8%	24,7 k €	-42.8%	43,1 k €	-21.6%	55 k €	-7.5%	59,4 k €	+19.7%	49,6 k €	+70.7%	29,1 k €	+559%	4,4 k €	-84.0%	27,6 k €	+104%	13,6 k €	-58.3%	32,6 k €	-19.2%	40,3 k €	+3.8%	38,8 k €	-39.4%	64 k €
Balance sheet
Equity	725 k €	-2.8%	745,5 k €	+11.8%	666,6 k €	+4.3%	639 k €	+3.0%	620,3 k €	+1.9%	608,6 k €	+2.4%	594,1 k €	+11.7%	532 k €	+8.8%	488,9 k €	+12.7%	434 k €	+11.0%	390,8 k €	+8.8%	359,2 k €	+3.7%	346,4 k €	+1.3%	341,9 k €	+8.8%	314,3 k €	+4.5%	300,8 k €	+12.1%	268,2 k €	+17.7%	227,9 k €	+20.5%	189 k €
Total assets	966,9 k €	+4.7%	923,6 k €	-1.1%	934,1 k €	+2.7%	909,8 k €	+5.3%	864 k €	+0.5%	860 k €	-0.3%	862,3 k €	+1.2%	852,4 k €	-0.6%	857,9 k €	+0.4%	854,2 k €	-1.1%	863,7 k €	-0.5%	868,4 k €	-1.5%	881,6 k €	+0.6%	876,4 k €	+0.9%	868,5 k €	-1.4%	880,9 k €	-1.2%	891,3 k €	-0.3%	893,5 k €	+3.9%	860 k €
Cash	15,4 k €	+360%	3,4 k €	-67.4%	10,3 k €	+73.9%	5,9 k €	+394%	1,2 k €	-51.1%	2,4 k €	-50.9%	5 k €		–		4,9 k €	+939%	475,2 €	-94.3%	8,3 k €	-48.6%	16,1 k €	+46.8%	11 k €	+43.3%	7,7 k €	+1052%	665,1 €	-93.2%	9,8 k €	+85.2%	5,3 k €	-43.8%	9,4 k €	+70.4%	5,5 k €
Debts	241,9 k €	+35.8%	178,1 k €	-33.4%	267,6 k €	-1.2%	270,8 k €	+11.1%	243,7 k €	-3.1%	251,4 k €	-6.3%	268,3 k €	-16.3%	320,4 k €	-13.2%	369 k €	-12.2%	420,3 k €	-11.1%	472,9 k €	-7.1%	509,3 k €	-4.9%	535,3 k €	+0.2%	534,4 k €	-3.6%	554,2 k €	-4.2%	578,3 k €	-7.2%	623,1 k €	-6.1%	663,6 k €	-1.1%	671 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 18 ended

Active mandates

CHRISTINE WINNEPENNINCKX

Managing director · since 28 novembre 2023

Active

XAVIER VAN MULLEM

Managing director · since 28 novembre 2023

Active

Ended mandates

CHRISTINE WINNEPENNINCKX

Managing director · since 28 novembre 2023 · until 28 novembre 2023

Ended

XAVIER VAN MULLEM

Managing director · since 28 novembre 2023 · until 28 novembre 2023

Ended

PHARMATRENTE

Manager · since 01 septembre 2016 · until 01 septembre 2019 · 0859.701.694

Represented by Christine WINNEPENNINCK

Ended

CHRISTINE WINNEPENNINCK

Manager · since 24 juin 2016 · until 24 juin 2023

Ended

At this address

Other companies at this address

Company	CBE no.
Alphar C Winnepenninckx● Active	0808.294.763
Association des copropriétaires de l'immeuble sis Chée de Charleroi 42 à Gilly● Active	0889.128.427
PHARMATRENTE● Active	0859.701.694

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/06/2026	06/06/2025	02/07/2024	12/06/2023	27/07/2022	11/08/2021
General meeting	15/05/2026	08/05/2025	10/05/2024	11/05/2023	12/05/2022	14/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	15/05/2026	12/06/2026	French	PDF
Micro model	31/12/2024	08/05/2025	06/06/2025	French	PDF
Micro model	31/12/2023	10/05/2024	02/07/2024	French	PDF
Micro model	31/12/2022	11/05/2023	12/06/2023	French	PDF
Micro model	31/12/2021	12/05/2022	27/07/2022	French	PDF
Micro model	31/12/2020	14/05/2021	11/08/2021	French	PDF
Micro model	31/12/2019	14/05/2020	26/08/2020	French	PDF
Micro model	31/12/2018	09/05/2019	26/08/2019	French	PDF
Micro model	31/12/2017	11/05/2018	22/08/2018	French	PDF
Micro model	31/12/2016	11/05/2017	25/08/2017	French	PDF
Abridged model	31/12/2015	12/05/2016	30/08/2016	French	PDF
Full model	31/12/2014	15/05/2015	26/08/2015	French	PDF
Full model	31/12/2013	08/05/2014	25/08/2014	French	PDF
Full model	31/12/2012	10/05/2013	28/08/2013	French	PDF
Full model	31/12/2011	10/05/2012	20/06/2012	French	PDF
Full model	31/12/2010	30/06/2011	26/08/2011	French	PDF
Full model	31/12/2009	25/06/2010	26/08/2010	French	PDF
Full model	31/12/2008	17/06/2009	20/06/2009	French	PDF
Full model	31/12/2007	07/06/2008	24/06/2008	French	PDF
Full model	31/12/2006	31/05/2007	21/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 18 ended

Active mandates

CHRISTINE WINNEPENNINCKX

Managing director · since 28 novembre 2023

Active

XAVIER VAN MULLEM

Managing director · since 28 novembre 2023

Active

Ended mandates

CHRISTINE WINNEPENNINCKX

Managing director · since 28 novembre 2023 · until 28 novembre 2023

Ended

XAVIER VAN MULLEM

Managing director · since 28 novembre 2023 · until 28 novembre 2023

Ended

PHARMATRENTE

Manager · since 01 septembre 2016 · until 01 septembre 2019 · 0859.701.694

Represented by Christine WINNEPENNINCK

Ended

CHRISTINE WINNEPENNINCK

Manager · since 24 juin 2016 · until 24 juin 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates30/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Registered office01/04/2016
SIEGE SOCIAL
PDF
Other15/04/2011
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Mandates28/09/2010
DEMISSIONS, NOMINATIONS
PDF
Registered office26/04/2010
SIEGE SOCIAL
PDF
Mandates03/09/2009
DEMISSIONS, NOMINATIONS
PDF
Mandates21/06/2007
DEMISSIONS, NOMINATIONS
PDF
Mandates06/12/2006
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025104,8 k €↑
2024
Annual accounts 2024101,4 k €↑
2023
Annual accounts 202380,1 k €↑
2022
Annual accounts 202248,7 k €↑
2021
Annual accounts 202147,7 k €↑
2020
Annual accounts 202029 k €↑
2019
Annual accounts 201924,7 k €↓
2017
Annual accounts 201743,1 k €↓
2016
Annual accounts 201655 k €↓
2015
Annual accounts 201559,4 k €↑
2014
Annual accounts 201449,6 k €↑
2013
Annual accounts 201329,1 k €↑
2012
Annual accounts 20124,4 k €↓
2011
Annual accounts 201127,6 k €↑
2010
Annual accounts 201013,6 k €↓
2009
Annual accounts 200932,6 k €↓
2008
Annual accounts 200840,3 k €↑
2007
Annual accounts 200738,8 k €↓
2006
Annual accounts 200664 k €
16/06/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ALPHAR GILLY

Overview

What does ALPHAR GILLY do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline